Evidence map›Paper›PMID 40575909›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Real-time monitoring of excess mortality under a new endemic regime.

Sasikiran Kandula, Birgitte F de Blasio, Marissa LeBlanc

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sasikiran KandulaNorwegian Institute of Public Health, Oslo, Norway.
Birgitte F de BlasioNorwegian Institute of Public Health, Oslo, Norway.
Marissa LeBlancNorwegian Institute of Public Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDMonitoring of mortality to identify trends and detect deviations from normal levels is an essential part of routine surveillance. In many European countries, disruptions in mortality patterns from the COVID-19 pandemic have required revisions to expected mortality estimates (and models) in the current endemic phase of SARS-CoV-2.AIMTo identify essential characteristics for future mortality surveillance and describe two Bayesian methods that satisfy these criteria while being robust to past periods of high COVID-19 mortality. We demonstrate their application in 19 European countries and subnational estimates in the United States, and report measures of model calibration.METHODSWe used a generalised additive model (GAM) with smoothed spline terms for annual trend and within-year seasonality and a generalised linear model (GLM) with a Serfling component for within-year seasonality and breakpoints to detect trend changes in trend. Both approaches modelled change in population size and group-specific (age and sex) mortality patterns.RESULTSModels were well-calibrated and able to estimate national and group-specific mortality before and during the acute COVID-19 pandemic phase. The effect of inclusion of mortality from the acute pandemic period was primarily an increase in uncertainty in expected mortality over the projection period. The GAM approach had better calibration and less variability in bias among countries.CONCLUSIONModels that can adapt to mortality anomalies seen during the acute COVID-19 pandemic period without a need for adjustments to observational data, or tailoring of model specifications, are feasible. The proposed methods can complement operational national and inter-agency surveillance systems currently used in Europe.

Indexed as

COVID-19Endemic DiseasesMortalityPopulation SurveillanceBayes TheoremEuropeFemaleHumansMalePandemicsSARS-CoV-2SeasonsUnited Statesbreak pointsCOVID-19endemicitygeneralised additive modelsmortality surveillance

Identifiers

PMID40575909
PMCPMC12207195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.